Jinhong Jiang
Jiangsu Province Key Laboratory Of Anesthesiology
Xuzhou, 221004, China
Xuzhou, 221004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
TIM3 alleviates microglia-mediated neuroinflammation in neuropathic pain by negatively regulating glycolysis-driven NLRP3 inflammasome activation.
Journal: Acta biochimica et biophysica Sinica
Published: July 01, 2026
Targeting the oxidative stress-neuroinflammation axis: the mechanism of arctigenin's broad-spectrum analgesia with limited side effects.
Journal: Frontiers in immunology
Published: November 26, 2025
MOTS-c Protects Against Acetaminophen-induced Liver Injury through the MAPK Signaling Pathway.
Journal: Protein and peptide letters
Published: August 26, 2025
TIM3 attenuates morphine antinociceptive tolerance and microglial neuroinflammation by suppressing the TRAF6/NF-κB pathway in male mice.
Journal: Neuropharmacology
Published: May 01, 2025
MOTS-c is an effective target for treating cancer-induced bone pain through the induction of AMPK-mediated mitochondrial biogenesis.
Journal: Acta biochimica et biophysica Sinica
Published: May 08, 2024
Mitochondria-derived peptide is an effective target for treating streptozotocin induced painful diabetic neuropathy through induction of activated protein kinase/peroxisome proliferator-activated receptor gamma coactivator 1alpha -mediated mitochondrial biogenesis.
Journal: Molecular pain
Published: April 24, 2024
All-Hydrocarbon Stapled Peptide Multifunctional Agonists at Opioid and Neuropeptide FF Receptors: Highly Potent, Long-Lasting Brain Permeant Analgesics with Diminished Side Effects.
Journal: Journal of medicinal chemistry
Published: December 14, 2023
Sleep-wake dependent hippocampal regulation of fear memory.
Journal: Sleep medicine
Published: November 22, 2023
Central and peripheral mechanism of MOTS-c attenuates pain hypersensitivity in a mice model of inflammatory pain.
Journal: Neurological research
Published: October 29, 2023
Tumor necrosis factor α-induced protein 8-like-2 controls microglia phenotype via metabolic reprogramming in BV2 microglial cells and responses to neuropathic pain.
Journal: The international journal of biochemistry & cell biology
Published: June 16, 2023
Mitochondrial-Derived Peptide MOTS-c Ameliorates Spared Nerve Injury-Induced Neuropathic Pain in Mice by Inhibiting Microglia Activation and Neuronal Oxidative Damage in the Spinal Cord via the AMPK Pathway.
Journal: ACS chemical neuroscience
Published: June 07, 2023
Tumor necrosis factor-α-induced protein 8-like 2 alleviates morphine antinociceptive tolerance through reduction of ROS-mediated apoptosis and MAPK/NF-κB signaling pathways.
Journal: Neuropharmacology
Published: December 11, 2022
Last Updated: 09/26/2026